Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast Alternate Day Dosing Safety in COPD
NCT01849341Phase 4Completed
- Sponsor
- Andalusian Progress and Health Public Foundation
- Start
- Jul 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of roflumilast in chronic obstructive pulmonary disease (COPD), sponsored by Andalusian Progress and Health Public Foundation. Started Jul 2012; status: completed.
02
Drugs
roflumilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01849341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01849341.